Literature DB >> 26011102

Increased tumor cell expression of Axl is a marker of aggressive features in breast cancer among African women.

Lavina Ahmed1,2, Hawa Nalwoga1, Jarle B Arnes3, Henry Wabinga4, David R Micklem2, Lars A Akslen1,3.   

Abstract

Axl, a receptor tyrosine kinase belonging to the Tyro/Axl/Mer (TAM) family, has been shown to be overexpressed in breast cancer with poor outcome. Moreover, Axl was associated with a basal-like phenotype (BLP) in these tumors. Our aim was to investigate Axl expression in breast cancers from an African population since these tumors are known to be aggressive and have a high frequency of the basal-like phenotype. We studied 170 paraffin-embedded breast carcinoma cases by tissue microarrays and immunohistochemical methods. In total, 128 tumor cases (75%) had strong Axl expression and 42 cases (25%) had weak or negative staining. Strong expression of Axl was associated with high tumor grade (p < 0.0005), estrogen receptor (ER) negativity (p = 0.024), p53 expression (p = 0.004), P-cadherin positivity (p = 0.017), and basal-like phenotypic profiles BLP2 (p = 0.033) and BLP3 (p = 0.022). In addition, Axl overexpression also showed an association with markers of tumor cell proliferation and tumor angiogenesis. In conclusion, our findings indicate strong expression of Axl in a high proportion of breast cancer cases among African women and associations with markers of aggressive features, indicating poor prognosis. These findings suggest Axl as a potential therapeutic target in this population.
© 2015 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Axl; Basal-like breast cancer; angiogenesis

Mesh:

Substances:

Year:  2015        PMID: 26011102     DOI: 10.1111/apm.12403

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  5 in total

1.  Expression of Axl and its prognostic significance in human breast cancer.

Authors:  Gaoyuan Jin; Zhenzhen Wang; Jianguang Wang; Like Zhang; Yanbin Chen; Pengfei Yuan; Dechun Liu
Journal:  Oncol Lett       Date:  2016-12-20       Impact factor: 2.967

2.  Targeting AXL and RAGE to prevent geminin overexpression-induced triple-negative breast cancer metastasis.

Authors:  Daniel Ryan; Jim Koziol; Wael M ElShamy
Journal:  Sci Rep       Date:  2019-12-16       Impact factor: 4.379

Review 3.  AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations.

Authors:  Italia Falcone; Fabiana Conciatori; Chiara Bazzichetto; Emilio Bria; Luisa Carbognin; Paola Malaguti; Gianluigi Ferretti; Francesco Cognetti; Michele Milella; Ludovica Ciuffreda
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

4.  Receptor-Defined Breast Cancer in Five East African Countries and Its Implications for Treatment: Systematic Review and Meta-Analysis.

Authors:  Pallvi Popli; Elane M Gutterman; Coral Omene; Shridar Ganesan; Douglas Mills; Richard Marlink
Journal:  JCO Glob Oncol       Date:  2021-02

5.  Strong Expression of Hypoxia-Inducible Factor-1α (HIF-1α) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer.

Authors:  Hawa Nalwoga; Lavina Ahmed; Jarle B Arnes; Henry Wabinga; Lars A Akslen
Journal:  PLoS One       Date:  2016-01-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.